Sijmen de Vries
Chief Executive Officer at PHARMING GROUP N.V.
Net worth: 8 M $ as of 2024-04-29
Profile
Sijmen de Vries is currently the Chief Executive Officer & Executive Director at Pharming Group NV.
He is also the Chief Executive Officer at Pharming Intellectual Property BV and a Non-Executive Director at Sylus Pharmaceuticals Ltd.
Additionally, he serves as an Independent Non-Executive Director at Biodexa Pharmaceuticals Plc and as a Finish Partner at BioConnection BV.
In his former positions, Dr. de Vries was the Chief Executive Officer at Morphochem AG and 4-Antibody AG.
He also served as a Non-Executive Director at Midatech Ltd.
from 2004 to 2015.
Dr. de Vries holds a doctorate degree from the University of Amsterdam and an MBA from Ashridge Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARMING GROUP NV
1.28% | 2024-05-19 | 8,594,721 ( 1.28% ) | 8 M $ | 2024-04-29 |
| 2023-04-16 | 1,322 ( 0.00% ) | 0 $ | 2024-01-30 |
Sijmen de Vries active positions
| Companies | Position | Start |
|---|---|---|
| PHARMING GROUP N.V. | Chief Executive Officer | 2008-10-12 |
| BIODEXA PHARMACEUTICALS PLC | Director/Board Member | 2014-11-12 |
| Sylus Pharmaceuticals Ltd. | Director/Board Member | 2010-06-20 |
Pharming Intellectual Property BV
 Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Chief Executive Officer | - |
BioConnection BV
 BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands. | Corporate Officer/Principal | - |
Former positions of Sijmen de Vries
| Companies | Position | End |
|---|---|---|
Midatech Ltd.
 Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 2015-03-12 |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Chief Executive Officer | - |
Morphochem AG
 Morphochem AG Miscellaneous Commercial ServicesCommercial Services Morphochem AG discovers and develops drugs. It focuses on finding therapeutic agents to treat cancer, anti-infectives, inflammation, metabolic disorders and infectious diseases, with particular emphasis on enzyme inhibitors. The company has developed an integrated chemical genomics drug discovery engine that it is applying in third party research programs and for building its own fully owned pipeline. Morphochem is headquartered in Munich, Germany. | Chief Executive Officer | - |
Training of Sijmen de Vries
| Ashridge Business School | Masters Business Admin |
| University of Amsterdam | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| Private companies | 6 |
|---|---|
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Morphochem AG discovers and develops drugs. It focuses on finding therapeutic agents to treat cancer, anti-infectives, inflammation, metabolic disorders and infectious diseases, with particular emphasis on enzyme inhibitors. The company has developed an integrated chemical genomics drug discovery engine that it is applying in third party research programs and for building its own fully owned pipeline. Morphochem is headquartered in Munich, Germany. | Commercial Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
| Sylus Pharmaceuticals Ltd. | |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Health Technology |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Producer Manufacturing |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Sijmen de Vries
